Sponsored message
Logged in as
Audience-funded nonprofit news
radio tower icon laist logo
Next Up:
0:00
0:00
Subscribe
  • Listen Now Playing Listen
NPR News

Study: Testosterone Supplements Can Be Safe

One year ago, Congress defunded public media. Now that we're 100% community funded, please become a sustaining member or increase your existing membership today.

Listen 0:00
Listen

An increasing number of aging men think they've found the way to feel young again -- by taking supplements of the male hormone testosterone. But doctors worry that testosterone supplements could increase the risks of prostate cancer.

A study in this week's Journal of the American Medical Association offers some reassurance, but it doesn't completely absolve the hormone.

As boys grow, testosterone helps to develop their reproductive tract; it also helps sprout facial hair, thicken vocal chords, and increase strength and libido.

Men reach their testosterone peak at about age 30. After that, levels in the blood decrease by about one percent a year. That means that a 65-year-old man could easily have about one-third less testosterone than he did when he was younger.

There have been no conclusive studies proving that testosterone has helped men in that position.

Most studies are small and short-term. Some have even suggested risk: an increase in red blood cell production, which can thicken blood and make patients more vulnerable to heart attack and stroke. There are also concerns about prostate cancer.

But researchers at UCLA find that after six months of use, the hormone does not appear to affect prostate tissue.

Sponsored message

Urologist Dr. Leonard Marks, who headed the study, says, "The placebo-treated men actually had more cancers than the testosterone-treated men -- all small cancers, but some were clinically significant. But there was certainly no carcinogenic effect of [testosterone therapy] that we could identify."

Marks says the study is good news for short-term use of testosterone -- to help build muscle mass in burn patients, for example -- or for HIV patients suffering from wasting syndrome. But Marks says the study was small, just 44 men. So, the safety of long term use, he says, is still a question.

Copyright 2022 NPR. To see more, visit https://www.npr.org.

One year ago, Congress voted to defund public media, eliminating a critical $1.7 million from our budget every year going forward. But they couldn’t silence us, and we’re not going anywhere. LAist is now 100% community funded and that means we’re taking our future into our own hands and turning to you to keep local reporting strong.

You come to LAist because you want independent reporting and trustworthy local information. Our nonprofit newsroom doesn’t answer to shareholders looking to turn a profit. Instead, we answer to you and our communities. We are free to follow facts wherever they lead and to hold power to account without fear or favor. Our only loyalty is to our readers and listeners and our mission: to inform, engage, and strengthen Southern California’s communities.

If this story helped you, please become a monthly member today to help sustain this mission. It just takes 1 minute to donate below.
Senior Vice President News, Editor in Chief

Make your tax-deductible donation today